Compositions for inhalation
US6632456B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 24, 1997 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Oct 24, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/145
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition including a mixture of active compounds (A) a pharmaceutically active polypeptide, and (B) an enhancer compound which enhances the systemic absorption of the polypeptide in the lower respiratory tract of a patient, the mixture being in the form of a dry powder for inhalation in which at least 50% of the total mass of the active compounds consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.